April 1, 2026 Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
April 1, 2026 Paragonix to Present Extensive Organ Transplant Research at the 46th Annual International Society of Heart and Lung Transplantation Meeting
April 1, 2026 Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides